この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
市場規制 · 1994/2/231 分で読めます
Synchronal Corporation, et al.; Proposed Consent Agreement With Analysis To Aid Public Comment
ローカル自動翻訳 · 情報源の原言語
概要
In settlement of alleged violations of federal law prohibiting unfair acts and practices and unfair methods of competition, this consent agreement, accepted subject to final Commission approval, would prohibit, among other things, Thomas L. Fenton, a former officer of Synchronal Corporation, from disseminating a purported baldness cure infomerical, for a product called Omexin; from misrepresenting that any commercial is an independent program; and from making unsubstantiated claims for any food, drug or device in the future.
情報源の原言語: Federal Register — Federal Trade Commission原文の発表を開く →